You searched for Parkinson's - Page 17 of 19

In Depth 20 Apr 2020

How Has Coronavirus Affected Europe’s Biotech Stocks?

…its registrational study of its Parkinson’s disease candidate.” While many drugs are being delayed, it is also noteworthy that governments worldwide are willing to offer a vaccine to their citizens…

April 20, 2020 - 12 minutesmins - By Carlos de Rojas

News and Trends 2 Mar 2023

Ten new companies join BioInnovation Institute’s Venture Lab program

…metastasis and determine the optimal chemotherapy; NorFalk, which produces sustainable surfactants; and Amplify Therapeutics, which is developing disease-modifying therapies for Gaucher disease and genetic subgroups of Parkinson’s disease. Since its…

March 2, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 10 Jul 2019

The Top 10 Biotechs You’ll Find in Lyon

…targeting neurons to enhance their effect. Founded in 2013, Theranexus has three drug candidates being tested in clinical trials to treat narcolepsy, sleepiness in Parkinson’s disease, Alzheimer’s, and neuropathic pain….

July 10, 2019 - 6 minutesmins - By Clara Rodríguez Fernández

News and Trends 21 Mar 2025

Depression drug trials are failing—and placebos are to blame

…treatment-resistant depression. American healthcare company Abbott has begun a pivotal clinical trial, having previously been successful in helping manage Parkinson’s disease and essential tremor symptoms. Meanwhile, Neurocrine Biosciences has launched…

March 21, 2025 - 9 minutesmins - By Roohi Mariam Peter

News and Trends 2 Mar 2023

Antiverse identifies therapeutic antibodies targeting GPCRs

…Scale, as well as existing investors, Tensor Ventures, Deep Science Ventures, Ed Parkinson and Development Bank of Wales (DBW). Murat Tunaboylu, co-founder and CEO of Antiverse, said: “This is the…

March 2, 2023 - 3 minutesmins - By Jim Cornall

huntingtons disease dementia prilenia therapeutics

News and Trends 5 Jun 2020

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

…and the neurodegenerative condition Parkinson’s disease. “Pridopidine’s mechanism as a sigma-1 receptor agonist is relevant to multiple neurodegenerative diseases as it rescues cellular processes that are commonly impaired in several…

June 5, 2020 - 3 minutesmins - By Helen Albert

News and Trends 6 Jun 2020

Boost For Inflammatory Disease Biotech NodThera With €49M Series B

…fibrosis…to inflammatory bowel disease, neurodegenerative diseases such as Alzheimer’s and Parkinson’s, and certain cancers.” Research suggests that selectively blocking the action of the NLRP3 inflammasome can help treat the overactivation…

June 6, 2020 - 3 minutesmins - By Helen Albert

News and Trends 15 May 2023

Alzheimer’s drugs could result from immune brain cell discovery

…for proper brain development and function. Cognitive decline is a common feature of neurodegenerative and psychiatric conditions like Alzheimer’s and Parkinson’s disease, schizophrenia and depression,” said Vassilis Stratoulias, senior researcher…

May 15, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 16 Feb 2022

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

…develop drugs for Parkinson’s and other related disorders. Autolus Therapeutics Founded: 2014 A spin-out of University College London, Autolus Therapeutics develops CAR-T cell therapies for cancer. The approach consists of…

February 16, 2022 - 6 minutesmins - By Clara Rodríguez Fernández

Opinion 10 Nov 2021

Automation Can Solve Diversity Issues in Clinical Trial Recruitment

…morning, while some younger people prefer to receive texts in the afternoon. We are working on a study with Queen Mary University of London in Parkinson’s disease, where diabetes is…

November 10, 2021 - 6 minutesmins - By External Contributor

Interview 16 Nov 2017

Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics

…in oncology: “At the moment, I’m very committed to the fight against cancer, but there’s an enormous amount of other very challenging diseases… like Alzheimer’s, Parkinson’s disease… and rare diseases……

November 16, 2017 - 6 minutesmins - By Alex Dale

News and Trends 26 Jun 2023

AbbVie takes step forward in Europe with migraine drug

…aims to democratize medicine by developing affordable vaccines for chronic conditions such as migraines, Alzheimer’s and Parkinson’s — to name a few. By combining the power of mAbs and the…

June 26, 2023 - 4 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

How Has Coronavirus Affected Europe’s Biotech Stocks?

Ten new companies join BioInnovation Institute’s Venture Lab program

The Top 10 Biotechs You’ll Find in Lyon

Depression drug trials are failing—and placebos are to blame

Antiverse identifies therapeutic antibodies targeting GPCRs

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

Boost For Inflammatory Disease Biotech NodThera With €49M Series B

Alzheimer’s drugs could result from immune brain cell discovery

Top 10 Biotech Companies in Stevenage, UK’s Hidden Life Sciences Gem

Automation Can Solve Diversity Issues in Clinical Trial Recruitment

Waking Up the Immune System with Luc Dochez, CEO of Tusk Therapeutics

AbbVie takes step forward in Europe with migraine drug

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!